Pliant Therapeutics Target Price

Pliant Therapeutics target price — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.08

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-03-12	Piper SandlerYasmeen Rahimi	$3	177.8% upside
2025-03-03	Stifel Nicolaus	$3	177.8% upside
2025-03-03	Leerink Partners	$2	85.2% upside
2024-09-13	H.C. WainwrightEd Arce	$38	3418.5% upside
2024-09-09	Leerink PartnersFaisal Khurshid	$33	2955.6% upside
2024-05-23	Piper SandlerYasmeen Rahimi	$40	3603.7% upside
2024-05-07	Stifel NicolausAlex Thompson	$32	2863% upside
2024-05-07	OppenheimerJeff Jones	$48	4344.4% upside
2024-05-07	H.C. WainwrightEd Arce	$36	3233.3% upside
2024-05-07	RBC CapitalBrian Abrahams	$45	4066.7% upside
2022-12-07	J.P. Morgan	$42	3788.9% upside

Pliant Therapeutics (PLRX) FAQ

Stockcircle tracks target price for Pliant Therapeutics (PLRX), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Pliant Therapeutics's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main PLRX overview so you can move from this figure to the surrounding analysis quickly.